Cresco Labs Inc. Deferred Tax Expense Income
Cresco Labs Inc. (CRLBF) reported Deferred Tax Expense Income of -$13.24 million for the 12-month period ending 2023-12-31, per its 40-F filed 2024-03-18.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:DeferredTaxExpenseIncome · last filed 2024-03-18
| Period end | Deferred Tax Expense Income 12 month | Deferred Tax Expense Income 12 month as first filed |
|---|---|---|
| 2023-12-31 | -$13.24M 40-F · filed 2024-03-18 | |
| 2022-12-31 | -$17.00M 40-F · filed 2024-03-18 | |
| 2021-12-31 | -$37.73M 40-F · filed 2023-03-22 | |
| 2020-12-31 | -$19.92M 40-F · filed 2022-04-05 | -$4.45M 40-F/A · filed 2021-04-29 |
| 2019-12-31 | $1.18M 40-F/A · filed 2021-04-29 |